A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis.
Phase of Trial: Phase III
Latest Information Update: 30 Oct 2014
At a glance
- Drugs Baclofen (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors UCB
- 15 Sep 2009 Actual patient number (60) added as reported by ClinicalTrials.gov.
- 18 Sep 2006 New trial record.